Sustained release of bone morphogenetic protein 2 via coacervate improves the osteogenic potential of muscle-derived stem cells

Stem Cells Translational Medicine

Volumn 2, Issue 9, 2013, Pages 667-677

  Li, Hongshuai ^a   Johnson, Noah Ray ^b,c   Usas, Arvydas ^a   Lu, Aiping ^a   Poddar, Minakshi ^a   wang, Yadong ^b,c   Huard, Johnny ^a,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b University of Pittsburgh   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Adult stem cells; Bone; Cellular therapy; Clinical translation; Differentiation; Heparin; Muscle stem cells; Stem cell transplantation

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; HEPARIN; TRANSCRIPTION FACTOR RUNX;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; COACERVATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC MANIPULATION; HISTOLOGY; MOUSE; MUSCLE DERIVED STEM CELL; NONHUMAN; OSTEOBLAST; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; RADIOGRAPHY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; SUSTAINED DRUG RELEASE; WESTERN BLOTTING;

EID: 84883401281     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2013-0027     Document Type: Article

References (58)

1. Van de Putte KA, Urist MR. Osteogenesis in the interior of intramuscular implants of decalcified bone matrix. Clin Orthop Relat Res 1965;43:257-270.
2. Volek-Smith H, Urist MR. Recombinant human bone morphogenetic protein (rhBMP) induced heterotopic bone development in vivo and in vitro. Proc Soc Exp Biol Med 1996;211: 265-272.
3. Mastrogiacomo M, Derubeis AR, Cancedda R. Bone and cartilage formation by skeletal muscle derived cells. J Cell Physiol 2005; 204:594-603.
4. Levy MM, Joyner CJ, Virdi AS et al. Osteoprogenitor cells of mature human skeletal muscle tissue: An in vitro study. Bone 2001;29: 317-322.
5. Bosch P, Musgrave DS, Lee JY et al. Osteoprogenitor cells within skeletal muscle. J Orthop Res 2000;18:933-944.
6. Asakura A, Komaki M, Rudnicki M. Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 2001;68:245-253.
7. Tajbakhsh S, Rocancourt D, Buckingham M. Muscle progenitor cells failing to respond to positional cues adopt non-myogenic fates in myf-5 null mice. Nature 1996;384:266-270.
8. Deasy BM, Jankowski RJ, Huard J. Musclederived stem cells: Characterization and potential for cell-mediated therapy. Blood Cells Mol Dis 2001;27:924-933.
9. Qu-Petersen Z, Deasy B, Jankowski R et al. Identification of a novel population of muscle stem cells in mice: Potential for muscle regeneration. J Cell Biol 2002;157:851-864.
10. Gharaibeh B, Lu A, Tebbets J et al. Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat Protoc 2008;3: 1501-1509.
11. Lee JY, Qu-Petersen Z, Cao B et al. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 2000;150:1085-1100.
12. Zheng B, Cao B, Crisan M et al. Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat Biotechnol 2007;25:1025-1034.
13. Lee JY, Musgrave D, Pelinkovic D et al. Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J Bone Joint Surg Am 2001;83-A:1032-1039.
14. Wright V, Peng H, Usas A et al. BMP4- expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. Mol Ther 2002;6:169-178.
15. Oshima H, Payne TR, Urish KL et al. Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther 2005;12:1130-1141.
16. Matsumoto T, Cooper GM, Gharaibeh B et al. Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-1. Arthritis Rheum 2009;60:1390-1405.
17. Gates CB, Karthikeyan T, Fu F et al. Regenerative medicine for the musculoskeletal system based on muscle-derived stem cells. J Am Acad Orthop Surg 2008;16:68-76.
18. Shen HC, Peng H, Usas A et al. Ex vivo gene therapy-induced endochondral bone formation: Comparison of muscle-derived stem cells and different subpopulations of primary muscle-derived cells. Bone 2004;34:982-992.
19. Musgrave DS, Bosch P, Lee JY et al. Ex vivo gene therapy to produce bone using different cell types. Clin Orthop Relat Res 2000; 378:290-305.
20. Kuroda R, Usas A, Kubo S et al. Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum 2006;54:433-442.
21. Usas A, Ho AM, Cooper GM et al. Bone regeneration mediated by BMP4-expressing muscle-derived stem cells is affected by delivery system. Tissue Eng Part A 2009;15:285-293.
22. Zhao B, Katagiri T, Toyoda H et al. Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein- 2. J Biol Chem 2006;281:23246-23253.
23. Jeon O, Song SJ, Kang SW et al. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparinconjugated poly(L-lactic-co-glycolic acid) scaffold. Biomaterials 2007;28:2763-2771.
24. Johnson NR, Wang Y. Controlled delivery of heparin-binding EGF-like growth factor yields fast and comprehensive wound healing. J Control Release 2013;166:124-129.
25. Chu H, Gao J, Chen CW et al. Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis. Proc Natl Acad Sci USA 2011;108:13444-13449.
26. Chu H, Gao J, Wang Y. Design, synthesis, and biocompatibility of an arginine-based polyester. Biotechnol Prog 2012;28:257-264.
27. Chu H, Johnson NR, Mason NS et al. A [polycation:heparin] complex releases growth factors with enhanced bioactivity. J Control Release 2011;150:157-163.
28. Peng H, Usas A, Gearhart B et al. Development of a self-inactivating tet-on retroviral vector expressing bone morphogenetic protein 4 to achieve regulated bone formation. Mol Ther 2004;9:885-894.
29. Li H, Ogle H, Jiang B et al. Cefazolin embedded biodegradable polypeptide nanofilms promising for infection prevention: A preliminary study on cell responses. J Orthop Res 2010;28:992-999.
30. Katagiri T, Yamaguchi A, Komaki M et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994; 127:1755-1766.
31. Jiao X, Billings PC, O'Connell MP et al. Heparan sulfate proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity in C2C12 cells. J Biol Chem 2007;282:1080-1086.
32. Zhou H, Qian J, Wang J et al. Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N,6-O-sulfated chitosan in vitro and in vivo. Biomaterials 2009;30:1715-1724.
33. Urish KL, Vella JB, OkadaMet al. Antioxidant levels represent a major determinant in the regenerative capacity of muscle stem cells. Mol Biol Cell 2009;20:509-520.
34. Kruyt MC, de Bruijn JD, Wilson CE et al. Viable osteogenic cells are obligatory for tissue- engineered ectopic bone formation in goats. Tissue Eng 2003;9:327-336.
35. Kruyt MC, Wilson CE, de Bruijn JD et al. The effect of cell-based bone tissue engineering in a goat transverse process model. Biomaterials 2006;27:5099-5106.
36. Friess W, Uludag H, Foskett S et al. Characterization of absorbable collagen sponges as recombinant human bone morphogenetic protein- 2 carriers. Int J Pharm 1999;185:51-60.
37. Martinek V, Latterman C, Usas A et al. Enhancement of tendon-bone integration of anterior cruciate ligament grafts with bone morphogenetic protein-2 gene transfer: A histological and biomechanical study. J Bone Joint Surg Am 2002;84-A:1123-1131.
38. Lieberman JR, Daluiski A, Einhorn TA. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am 2002;84-A:1032-1044.
39. Takahashi Y, Yamamoto M, Tabata Y. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta- tricalcium phosphate. Biomaterials 2005; 26:4856-4865.
40. Helm GA, Sheehan JM, Sheehan JP et al. Utilization of type I collagen gel, demineralized bone matrix, and bone morphogenetic protein- 2 to enhance autologous bone lumbar spinal fusion. J Neurosurg 1997;86:93-100.
41. Yang XB, Whitaker MJ, Sebald W et al. Human osteoprogenitor bone formation using encapsulated bone morphogenetic protein 2 in porous polymer scaffolds. Tissue Eng 2004;10: 1037-1045.
42. Noshi T, Yoshikawa T, Ikeuchi M et al. Enhancement of the in vivo osteogenic potential of marrow/hydroxyapatite composites by bovine bone morphogenetic protein. J Biomed Mater Res 2000;52:621-630.
43. Arnander C, Westermark A, Veltheim R et al. Three-dimensional technology and bone morphogenetic protein in frontal bone reconstruction. J Craniofac Surg 2006;17:275-279.
44. Villavicencio AT, Burneikiene S, Nelson EL et al. Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2. J Neurosurg Spine 2005;3:436-443.
45. Kanayama M, Hashimoto T, Shigenobu K et al. A prospective randomized study of posterolateral lumbar fusion using osteogenic protein- 1 (OP-1) versus local autograft with ceramic bone substitute: Emphasis of surgical exploration and histologic assessment. Spine 2006;31:1067-1074.
46. Chen RR, Mooney DJ. Polymeric growth factor delivery strategies for tissue engineering. Pharm Res 2003;20:1103-1112.
47. Ruppert R, Hoffmann E, Sebald W. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur J Biochem 1996;237:295-302.
48. Shimasaki S, Zachow RJ, Li D et al. A functional bone morphogenetic protein system in the ovary. Proc Natl Acad Sci USA 1999;96: 7282-7287.
49. Takada T, Katagiri T, Ifuku M et al. Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J Biol Chem 2003;278:43229-43235.
50. Pellegrini L. Role of heparan sulfate in fibroblast growth factor signalling: A structural view. Curr Opin Struct Biol 2001;11: 629-634.
51. Higashiyama S, Abraham JA, Klagsbrun M. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: Dependence on interactions with cell surface heparan sulfate. J Cell Biol 1993;122:933-940.
52. Friess W, Uludag H, Foskett S et al. Characterization of absorbable collagen sponges as rhBMP-2 carriers. Int J Pharm 1999;187:91-99.
53. Geiger M, Li RH, Friess W. Collagen sponges for bone regeneration with rh- BMP-2. Adv Drug Deliv Rev 2003;55:1613-1629.
54. Carlisle E, Fischgrund JS. Bone morphogenetic proteins for spinal fusion. Spine J 2005; 5:240S-249S.
55. Gautschi OP, Frey SP, Zellweger R. Bone morphogenetic proteins in clinical applications. Anz J Surg 2007;77:626-631.
56. Gupta MC, Maitra S. Bone grafts and bone morphogenetic proteins in spine fusion. Cell Tissue Bank 2002;3:255-267.
57. Robinson Y, Heyde CE, Tschoke SK et al. Evidence supporting the use of bone morphogenetic proteins for spinal fusion surgery. Expert Rev Med Devices 2008;5:75-84.
58. Williams DF. Some observations on the role of cellular enzymes in the in-vivo degradation of polymers. In: Syrett BC, Acharya A, eds. Corrosion and Degradation of Implant Materials. Baltimore, MD: American Society for Testing and Materials, 1979:61-75.